Canada markets close in 2 hours 14 minutes

IM Cannabis Corp. (IMCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5601-0.0032 (-0.57%)
As of 01:24PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.5633
Open0.5464
Bid0.5601 x 100
Ask0.5890 x 100
Day's Range0.5310 - 0.6499
52 Week Range0.1890 - 1.4300
Volume106,718
Avg. Volume685,895
Market Cap7.502M
Beta (5Y Monthly)1.90
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IMC to transfer its Oranim Pharmacy shares back to the seller

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.

  • PR Newswire

    IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, entered, through its subsidiary, a strategic distribution agreement with Vessel Brand Inc, a subsidiary of Flora Growth Corp. ("Flora"), a global consumer-packaged goods leader and pharmaceutical distributor, headquartered in Carlsbad, CA.

  • CNW Group

    Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive